PLSE
insider transactionsPULSE BIOSCIENCES, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-95.0K
30.0K buy · 125.0K sell
Net value · 365d
-$2.3M
$590.7K in · $2.9M out
Sentiment · 365d
Net selling
17% buying · 83% selling
Open-market trades · 365d
9
30.0K buy · 125.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
14.5K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
8.4K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Grant·A
Director
$0
3.8K sh
Own New
-
Grant·A
Director
$0
30.0K sh
Own New
-
Buy·P
Chief Executive Officer
$295.4K
15.0K sh · $19.69
Own +1773%
-
Buy·P
Chief Executive Officer
$295.4K
15.0K sh · $19.69
Own New
-
Grant·A
Chief Technology Officer
$0
100.0K sh
Own New
-
Exercise·M
Chief Commercial Officer · 10b5-1
$0
5.0K sh
Own +2%
-
Sell·S
Chief Commercial Officer · 10b5-1
$118.2K
5.0K sh · $23.64
Own -10%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$7.7K
5.0K sh · $1.53
Own +12%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$0
20.0K sh
Own +7%
-
Sell·S
Chief Commercial Officer · 10b5-1
$472.6K
20.0K sh · $23.63
Own -32%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$30.6K
20.0K sh · $1.53
Own +46%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$0
20.0K sh
Own +7%
-
Sell·S
Chief Commercial Officer · 10b5-1
$470.6K
20.0K sh · $23.53
Own -32%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$30.6K
20.0K sh · $1.53
Own +46%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$0
20.0K sh
Own +6%
-
Sell·S
Chief Commercial Officer · 10b5-1
$467.4K
20.0K sh · $23.37
Own -32%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$30.6K
20.0K sh · $1.53
Own +46%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$0
20.0K sh
Own +6%
-
Sell·S
Chief Commercial Officer · 10b5-1
$504.0K
20.0K sh · $25.20
Own -32%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$30.6K
20.0K sh · $1.53
Own +46%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$0
20.0K sh
Own +5%
-
Sell·S
Chief Commercial Officer · 10b5-1
$470.4K
20.0K sh · $23.52
Own -32%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$30.6K
20.0K sh · $1.53
Own +46%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$0
20.0K sh
Own +5%
-
Sell·S
Chief Commercial Officer · 10b5-1
$429.0K
20.0K sh · $21.45
Own -32%
-
Exercise·M
Chief Commercial Officer · 10b5-1
$30.6K
20.0K sh · $1.53
Own +46%
-
Grant·A
Director
$0
3.1K sh
Own New
-
Grant·A
Director
$0
50.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Mahkam Zanganeh | Grant A | 14.5K | $0 |
| Jun 11, 2026 | Mahkam Zanganeh | Grant A | 30.0K | $0 |
| Jun 11, 2026 | Richard Van Den Broek | Grant A | 8.4K | $0 |
| Jun 11, 2026 | Richard Van Den Broek | Grant A | 30.0K | $0 |
| Jun 11, 2026 | Manmeet Singh Soni | Grant A | 30.0K | $0 |
| Jun 11, 2026 | Maria Sainz | Grant A | 3.8K | $0 |
| Jun 11, 2026 | Maria Sainz | Grant A | 30.0K | $0 |
| May 11, 2026 | Paul A Laviolette KEY | Buy P | 15.0K | $295.4K |
| May 11, 2026 | Paul A Laviolette KEY | Buy P | 15.0K | $295.4K |
| Mar 23, 2026 | Darrin Uecker | Grant A | 100.0K | $0 |
| Feb 18, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 5.0K | $0 |
| Feb 18, 2026 | Kevin Patrick Danahy 10b5-1 | Sell S | 5.0K | $118.2K |
| Feb 18, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 5.0K | $7.7K |
| Feb 17, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $0 |
| Feb 17, 2026 | Kevin Patrick Danahy 10b5-1 | Sell S | 20.0K | $472.6K |
| Feb 17, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $30.6K |
| Feb 13, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $0 |
| Feb 13, 2026 | Kevin Patrick Danahy 10b5-1 | Sell S | 20.0K | $470.6K |
| Feb 13, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $30.6K |
| Feb 12, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $0 |
| Feb 12, 2026 | Kevin Patrick Danahy 10b5-1 | Sell S | 20.0K | $467.4K |
| Feb 12, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $30.6K |
| Feb 11, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $0 |
| Feb 11, 2026 | Kevin Patrick Danahy 10b5-1 | Sell S | 20.0K | $504.0K |
| Feb 11, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $30.6K |
| Feb 10, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $0 |
| Feb 10, 2026 | Kevin Patrick Danahy 10b5-1 | Sell S | 20.0K | $470.4K |
| Feb 10, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $30.6K |
| Feb 9, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $0 |
| Feb 9, 2026 | Kevin Patrick Danahy 10b5-1 | Sell S | 20.0K | $429.0K |
| Feb 9, 2026 | Kevin Patrick Danahy 10b5-1 | Exercise M | 20.0K | $30.6K |
| Feb 5, 2026 | Maria Sainz | Grant A | 3.1K | $0 |
| Jan 8, 2026 | Maria Sainz | Grant A | 50.0K | $0 |
About PLSE insider trading
This page tracks insider transactions for PULSE BIOSCIENCES, INC. (PLSE) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.